Pfizer requests COVID jab authorization for kids aged 5 to 11 despite serious health risks

(Lifesite News, Oct 7, 2021)
The company is seeking emergency use authorization for the age group despite research showing children are more likely to suffer serious effects from the vaccines than the virus.

Pfizer on Thursday officially requested an emergency use authorization (EUA) to dole out its experimental COVID vaccine to young children between the ages of 5 and 11.

In a Thursday tweet announcing the move, Pfizer argued that its request seeking an EUA from the Food and Drug Administration (FDA) is “an important step in our ongoing effort against #COVID19.”

“We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat,” the pharmaceutical company added.

The news comes in spite of the fact that children are at extremely low risk of suffering severe complications or death from contracting COVID-19, and regardless of studies showing the jabs themselves present significant health risks to young people.

School districts and governments have begun to mandate the jabs for “eligible” students attending classes during the 2021-2022 school year.

On Friday, California’s Democratic Gov. Gavin Newsom announced he would make the injections mandatory for all “eligible” students participating in in-person learning at both public and private schools.

The shots currently have an EUA for young people aged 12 to 15, while children under the age of 12 are considered “ineligible” to get the jab. The FDA already granted full approval for the Pfizer-BioNTech double-dose drug for anyone aged 16 or over in August.

If the FDA clears Pfizer’s request, all children attending public or private schools in California, from kindergarten through high school, will be required to get the shot.

The move to inoculate children against the coronavirus fails to acknowledge evidence that children are at extremely low risk of spreading or suffering serious effects from the coronavirus.

In July, a team of researchers with Johns Hopkins School of Medicine “analyze[d] approximately 48,000 children under 18 diagnosed with Covid in health-insurance data from April to August 2020,” finding a “mortality rate of zero among children without a pre-existing medical condition such as leukemia.”

Studies published after the jabs were authorized for teenagers have shown that young people, especially teenage boys, are at serious risk of developing severe side effects to the experimental COVID-19 drugs, including heart inflammation.

In June, Pfizer/BioNTech and Moderna were forced to add a risk of heart inflammation to the fact sheets for their COVID-19 drugs after 1,200 cases of heart inflammation after vaccination, mostly in males under age 30, were reported to the government.

Last month, a University of California-led study found that for teenage boys the risk of heart inflammation after getting a COVID shot was four to six times as high as the risk of being hospitalized with COVID-19.